Use of specific adrenergic receptor knockout (KO) mice has also been useful in defining the role of ␣ 1 AR subtypes in cardiovascular regulation. [3] [4] [5] [6] However, results in KO mice remain controversial, with each subtype contributing to regulation of blood pressure and vascular contractility but without a subtype-selective role being clearly apparent. The ␣ 1 A, B, and D AR subtypes have been shown to contribute to the maintenance of basal blood pressure and vasopressor responses to exogenous agonists. Specifically, ␣ 1A and ␣ 1D AR KO mice have lower basal blood pressure, whereas all 3 KO mice models have attenuated pressor responses to exogenous norepinephrine (NE). However, it is becoming increasingly appreciated that differential ␣ 1 AR-mediated responses may be the result of different receptor subtypes at junctional versus extrajunctional sites. 7-9 Thus, a critical and clinically relevant question in ␣ 1 AR adrenergic biology remains: is there a specific receptor subtype that mediates sympathetic transmission at the neuroeffector junction? 10 Clinical data suggest that orthostatic intolerance (OI) may result when ␣ 1B ARs are specifically inhibited. 11 Thus, we hypothesized that the ␣ 1B AR is the subtype critical in mediating vasoconstriction at the neuroeffector junction. To test the hypothesis, we measured integrated cardiovascular responses to selective carotid arterial baroreceptor unloading induced by transient bilateral carotid occlusion (TBCO) in mice with a homozygous deletion of the ␣ 1B AR gene. We also determined the vascular contractile responses in mesenteric resistance vessels in vitro to endogenous NE (mediated by electrical field stimulation [EFS]) in KO and wild-type (WT) mice.
F unctional studies with subtype-selective antagonists as well as differential mRNA studies suggest that different ␣-1 adrenergic receptor (␣ 1 AR) subtypes mediate contractile function in different vessel beds 1 and in arteries versus veins. 2 Use of specific adrenergic receptor knockout (KO) mice has also been useful in defining the role of ␣ 1 AR subtypes in cardiovascular regulation. [3] [4] [5] [6] However, results in KO mice remain controversial, with each subtype contributing to regulation of blood pressure and vascular contractility but without a subtype-selective role being clearly apparent. The ␣ 1 A, B, and D AR subtypes have been shown to contribute to the maintenance of basal blood pressure and vasopressor responses to exogenous agonists. Specifically, ␣ 1A and ␣ 1D AR KO mice have lower basal blood pressure, whereas all 3 KO mice models have attenuated pressor responses to exogenous norepinephrine (NE). However, it is becoming increasingly appreciated that differential ␣ 1 AR-mediated responses may be the result of different receptor subtypes at junctional versus extrajunctional sites. [7] [8] [9] Thus, a critical and clinically relevant question in ␣ 1 AR adrenergic biology remains: is there a specific receptor subtype that mediates sympathetic transmission at the neuroeffector junction? 10 Clinical data suggest that orthostatic intolerance (OI) may result when ␣ 1B ARs are specifically inhibited. 11 Thus, we hypothesized that the ␣ 1B AR is the subtype critical in mediating vasoconstriction at the neuroeffector junction. To test the hypothesis, we measured integrated cardiovascular responses to selective carotid arterial baroreceptor unloading induced by transient bilateral carotid occlusion (TBCO) in mice with a homozygous deletion of the ␣ 1B AR gene. We also determined the vascular contractile responses in mesenteric resistance vessels in vitro to endogenous NE (mediated by electrical field stimulation [EFS] ) in KO and wild-type (WT) mice.
Methods

Murine Species
Nineteen ␣ 1B AR Ϫ/Ϫ mice and 14 of their WT controls between 2 and 5 months of age were used in the study. The generation of the ␣ 1B AR KO mice has been described previously. 3 Mice were housed under diurnal lighting conditions and allowed food and tap water ad libitum. Animal treatment and care was provided in accordance with institutional guidelines, and the protocol was approved by the animal care and use committee of the Johns Hopkins University School of Medicine.
In Vivo-Integrated Cardiovascular Responses to Endogenous Sympathetic Activation
Carotid Artery Isolation, Isolation, and Sectioning of Aortic Depressor Nerve and Sympathetic Trunk Anesthesia was initiated with brief isoflurane inhalation followed by intraperitoneal injection of urethane (750 mg/kg), morphine (0.6 mg/kg), and etomidate (5.6 mg/kg) dissolved in deionized water. Supplemental intraperitoneal anesthesia (one-fifth dose) was provided if needed so the animals remained unresponsive to tail pinch by forceps, as assessed by changes in heart rate (HR) and blood pressure. Temperature was measured with a rectal probe and maintained at Ϸ37°C. Animals were intubated with a blunt 19-gauge needle via a tracheotomy and were ventilated with a customdesigned constant-pressure ventilator with 100% oxygen at 120 breaths per minute and a tidal volume of 200 L.
The cervical region was exposed via a midline ventral incision, the right and left thyroid lobes were retracted, and the sternomastoid muscles were retracted bilaterally. The sternohyoid was looped with 6.0 silk and retracted over the trachea to expose the common carotid sinus and artery region. Carotid arteries parallel to the trachea were carefully isolated. Afferent signals from the aortic arch baroreceptors were eliminated by bilaterally sectioning the aortic depressor nerve (ADN) and the sympathetic trunk (ST). To measure open-loop baroreceptor responses, selective arterial baroreceptor unloading was induced by transient occlusions of both carotid arteries (TBCO) for 10 to 15 seconds. The afferent neural signal in this protocol is generated by a decrease in blood pressure sensed by the carotid baroreceptors, distal to the point of carotid occlusion. The efferent response including blood pressure, HR, and myocardial contractility are then measured. However, the presence of baroreceptors in the aortic arch and heart, which lie proximal to the point of occlusion, will not sense a decrease in arterial pressure and will thus be capable of buffering the cardiovascular effector responses, hence the need for aortic arch baroreceptor deafferentation. The relative location of the ADN and ST has been published previously. 12 The ST is located directly adjacent to the vagus nerve and is much larger in diameter than the ADN. The ADN is delicate and small in diameter and is located in between the trachea and the vagus nerve, closely adherent to the ST or wrapping under and over the carotid artery.
Placement of Combined Micromanometric/ Conductance Catheter and Measurement of Pressure-Volume Loops With TBCO
The chest was entered through an anterior thoracotomy under a dissecting microscope, and a small apical stab was made at the left ventricle (LV) apex, leaving the pericardium partially intact. The conductance catheter (Millar 1.4-Fr; SPR-671) was then advanced retrograde into the LV along the cardiac longitudinal axis with the distal tip in the aortic root and proximal electrode just within the endocardial wall of the LV apex.
With the catheter(s) fixed in place, baseline values and responses to inferior vena cava (IVC) occlusions were recorded. These values were recorded again after the carotid arteries were bilaterally occluded and the transient cardiovascular responses reached an equilibrium level (usually 10 to 15 seconds). Recordings were performed twice.
An albumin/saline solution (12.5 g/dL) was infused through the left jugular vein via a 30-gauge needle initially at 50 L per minute for 4 minutes and then throughout the surgery at 10 L per minute.
Pressure-Volume Loop Data Analysis
Indices of myocardial systolic and diastolic performance were derived from pressure-volume (PV) data obtained at steady state and during transient unloading (vena caval occlusion [VCO]) of the heart. VCO was performed by rapid (1 to 2 seconds) complete compression of IVC with small forceps, during which a series of PV loops were recorded. Baseline and VCO readings were acquired for TBCO and non-TBCO states for WT and ␣ 1B AR KO mice. VCOmediated acute preload reduction allows the end-systolic PV relationship (ESPVR). Myocardial contractility can be indexed by the peak rate of rise in LV pressure divided by instantaneous pressure (dP/dt-IP) 13 and by the load-independent parameter end-systolic elastance (Ees). 14 Ees is the slope of the ESPVR. Although the ESPVR is nonlinear in mice, over the range of the data obtained by preload and afterload changes, the ESPVR can be considered linear. 15 End systole is measured as the point at peak elastance (peak P/V ratio). A linear regression line is then fit through these points and the slope derived.
Baseline cardiac preload was indexed as the left ventricular end-diastolic volume (EDV) and end-diastolic pressure. Cardiac afterload was evaluated with effective arterial elastance (Ea; ratio of LV systolic pressure to stroke volume). 16 This parameter is not preload dependent and has been validated to closely approximate total afterload, which incorporates systemic vascular resistance, aortic impedance, and the reflected wave properties of the vasculature. Systemic vascular resistance (Svr) is calculated as follows: Svrϭmean arterial pressure [MAP]Ϫright atrial pressure [RAP]/CO. Cardiac output can be calculated as the product of HR and stroke volume from PV loops. An estimate of MAP is derived from PV loop data and estimates of RAP from known measurements in mice. In this way, an estimate of Svr is made. Tau ln represents the time constant for relaxation, an accurate measure of diastolic function. We have used Tau ln, the time constant of relaxation derived from the monoexponential equation describing the rate of fall of ventricular pressure. This is a well-validated measure of the rate of diastolic relaxation. 17 
Mesenteric Microvessel Studies
A mesenteric resistance artery (diameter Ϸ180 to 250 m) was separated from the surrounding connective tissue and mesenteric vein in a HEPES physiological salt solution (PSS; in mmol/L buffer [135.5 NaCl, 5.9 KCl, 1.2 MgCl 2 , 11.6 HEPES, 11.5 glucose, and 2.2 CaCl 2 and was adjusted to a pH of 7.4]) on ice. Arteries were mounted on a dual-pipette pressure servo system (model PS/200/Q; Living Systems) at a constant static pressure of 60 mm Hg. The isolated vessel was superfused with HEPES and maintained at 37°C by an inline heater (SH-27B; Warner). The lumen of the vessel was perfused with HEPES PSS (as above). External vessel diameter was monitored and recorded using a videodimension analysis system (Ion-Optix Myocam). An electric stimulator (Grass SD9) and electrodes were used to establish an AC through the perfusion bath. The sympathetic nerves of the isolated vessel were field stimulated at 80 V, which represented a current of Ϸ200 mA. The pulse duration was 5 ms, and the pulse train length was Ϸ25 to 50 seconds (the time taken for the response to plateau). A dose response to NE was applied to the perfusion system at concentrations of 0.01 to 10 mol/L in one half log doses. In the electrical stimulation and the NE dose response, the vessel diameter reached a stable plateau at which point the vessel diameter was measured. This protocol was then repeated in the presence of 1 to 10 mol/L prazosin.
Statistical Analysis
All data are presented as meanϮSEM, with N being indicated for each experimental protocol. Statistical analyses were performed using unpaired Student t tests. A value of PϽ0.05 was considered significant. For dose-response curves, NE dose responses in mesen-
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teric microvessels, statistical analysis was done using 2-way ANOVA with Bonferonni post tests.
Results
Effect of ␣ 1B AR Deletion on Baseline Hemodynamic Data
We used a combined micromanometer conductance catheter to assess the determinants of cardiovascular performance in WT and ␣ 1B AR KO mice (Table 1 ). In anesthetized instrumented mice, baseline HR was similar in ␣ 1B AR KO mice and WT. In contrast, systolic blood pressure (SBP) and Ea were significantly lower, and LV chamber volume was significantly higher in the ␣ 1B AR KO mice compared with WT (Table 1) . Moreover, myocardial contractility was lower, as reflected by dP/dt. The baseline dP/dt-IP was also lower and demonstrated a trend toward significance ( Table 1) .
Effect of Selective Carotid Arterial Baroreceptor Unloading (TBCO) on Hemodynamic Parameters
To assess the hemodynamic responses to a hypotensive stimulus, both carotid arteries were transiently occluded (Ϸ10 to 15 seconds), after denervation of ADN and ST. These nerves are sectioned to prevent buffering of the responses by baroreceptors in the aortic arch. TBCO thus represents an open-loop baroreflex stimulus. PV loop data were then collected after transient IVC occlusion. As shown in Table 2 and Figure 1 , TBCO produced a significant pressor response (33Ϯ5% increase in SBP) in WT mice, consistent with intact baroreflex reactivity. In contrast, the pressor response was markedly attenuated in ␣ 1B AR KO mice (9Ϯ2% increase in SBP; PϽ0.001 versus WT). Although there was a small increase in HR after TBCO in WT mice (2Ϯ0.4%), there was a decrease in ␣ 1B A KO mice (Ϫ2Ϯ0.7%; Pϭ0.001 versus WT). TBCO stimulated enhanced myocardial contractility in WT mice (Table 2 ; Figure 1 ). Because TBCO is associated with significant changes in loading, the best load-independent measure of contractility (Ees) was used to assess the changes observed in contractility. There was a significant increase in the slope of the ESPVR (Ees) in WT mice (70Ϯ16%) after TBCO ( Table 2 ; Figure 1 ). In marked contrast, TBCO resulted in minimal increase in contractility in ␣ 1B AR KO mice (7Ϯ12%; PϽ0.01 versus WT). Most important, there was a significant increase in Ea in WT mice after TBCO, which was markedly attenuated in KO mice (Table 2) .
Mesenteric Vascular Responses to Endogenous (Periarterial EFS) and Exogenous NE
The profound attenuation in pressor responses to endogenous sympathetic activation in ␣ 1B AR KO mice prompted us to examine the in vitro vascular responses to endogenous and exogenous NE. There was no significant difference in the size of the mesenteric microvessels in WT and ␣ 1B AR KO mice (239Ϯ25 mm versus 227Ϯ25; WT versus KO; NS). Isolated, pressurized mesenteric microvessels were stimulated with periarterial platinum electrodes (to release endogenous neurotransmitters such as NE) or exogenous-applied NE. Electrical stimulation (2 to 10 Hz) resulted in a significant frequency-dependent reduction in vessel diameter ( Figure 2 ). This response was markedly inhibited by the nonspecific ␣ 1 AR antagonist prazosin. For example, in WT at 10 Hz, the vasoconstrictor response was decreased from 19.5Ϯ1.1% to 11.8Ϯ0.5% by prazosin (nϭ4 to 7; 10 Hz; WT versus WTϩprazosin; PϽ0.001). This suggests that a significant component of the vasoconstrictor response is mediated by ␣ 1 ARs, whereas the remainder is mediated by nonadrenergic cotransmitters (possibly neuropeptide Y and ATP). 18 In marked contrast to the WT vessels, there was a profound reduction in the response to 10 Hz EFS in the ␣ 1B AR KO mouse vessels (19.5Ϯ1.1% versus 9.1Ϯ1.1%; WT versus ␣ 1B AR KO; nϭ7 to 9; PϽ0.001). No difference could be observed between the non-␣ 1 AR-inhibitable portion of the responses in WT and KO mice (11.8Ϯ0.5% versus 9.1Ϯ1.1%; WTϩprazosin versus ␣ 1B AR KO; NS; Figure 2 ). Moreover, prazosin had no significant further effect on the response to EFS in ␣ 1B AR KO vessels (9.1Ϯ1 versus 8.7Ϯ1.9%; ␣ 1B AR KO versus ␣ 1B AR KOϩprazosin; NS). Exogenous NE resulted in a dose-dependent reduction in vessel diameter that was completely abolished by prazosin (maximum reduction in diameter; 33.4Ϯ4.3% versus 0.6Ϯ0.3%; WT versus WTϩprazosin; nϭ4 to 7; PϽ0.001; Figure 2 ). In contrast to the EFS, there was no significant difference in the contractile response to 10 mol/L NE in ␣ 1B AR KO mice versus WT (22.4Ϯ7.3% versus 33.4Ϯ4.3%; ␣ 1B AR KO versus WT; nϭ6 to 7; Figure 2 ). This suggests that the ␣ 1B AR plays a selective role in mediating contractile responses at the neuroeffector junction, whereas the other receptor subtypes (␣ 1A or ␣ 1D ) are likely important in mediating responses to exogenous catecholamines.
Discussion
The impaired pressor response to a hypotensive stimulus in the ␣ 1B AR KO mice, as well as the absent ␣ 1 AR-mediated vascular contraction to endogenous NE release (EFS), strongly suggests that the ␣ 1B AR is critical in mediating sympathetic transmission at the neuroeffector junction. Furthermore, the preserved vascular contractile response to exogenous NE supports the role for other ␣ 1 AR subtypes (␣ 1A or ␣ 1D ) in extrajunctional ␣ 1 AR signaling. In addition, the ␣ 1B AR appears to be important in maintaining myocardial contractile function because mice deficient in the ␣ 1B AR have impaired endogenously stimulated adrenergically mediated contractile reserve and develop dilated LVs, as reflected by an increase in ventricular EDV.
Role of the ␣ 1B AR in Sympathetic Neuroeffector Signaling in Blood Vessels
There is significant heterogeneity in the expression of ␣ 1 AR subtypes in vascular tissue. 1 However, there is a paucity of data to indicate which receptor subtype mediates sympathetic neurotransmission at the synaptic neuroeffector junction. The notion of the existence of different ␣ 1 AR subtypes in junctional versus extrajunctional neurovascular regions is supported by recent pharmacological studies in splenic arteries in vitro. 9, 19 Although periarterial EFS was inhibited by chloroethy-clonidine and LY-765 314 (␣ 1B AR specific antagonists), contractile responses to exogenous NE were preserved in an isolated canine splenic artery preparation. In contrast, WB4101, an ␣ 1A AR specific antagonist, inhibited exogenous NE-induced responses but had little effect on periarterial EFS-mediated vasoconstriction. The recent description of an ␣ 1B AR-specific circulating sympatholytic factor in a patient with orthostatic hypotension 11 also supports the notion of a differential distribution of ␣ 1 AR between junctional and extrajunctional regions. Preincubation of a porcine pulmonary artery (vascular ring bioassay) with sympatholytic dialyzed plasma attenuated the contractile response to exogenous phenylephrine but completely obliterated the response to periarterial EFS. Thus, our in vivo and in vitro vascular data support the concept that junctional receptors represent a different subtype to extrajunctional receptors and are most likely the ␣ 1B AR subtype. Evidence to support the role of ␣ 1D ARs and ␣ 1A ARs as extrajunctional receptors is provided indirectly by KO models. Specifically, the ␣ 1A AR and ␣ 1D AR KO mice demonstrated attenuated blood pressure responses to exogenous ␣ 1 agonists, 4,5 and the ␣ 1D AR KO mice demonstrate impaired contractile responses in mesenteric vessels and aortic rings to exogenous NE. 5 The clinical importance of this differential expression of adrenergic receptor subtypes is apparent in the selectivity displayed by certain ␣ 1 AR antagonists. For example, alfuzosin, a nonselective ␣ 1 AR antagonist, is associated with significant OI in males being treated for symptomatic benign prostatic hypertrophy. In contrast, tamsulosin, an ␣ 1A AR selective antagonist, is not associated with a greater incidence of OI than placebo. 20, 21 Thus, although the ␣ 1A and ␣ 1D AR may play a role in blood pressure regulation, the ␣ 1B AR is likely critical in mediating acute vascular responses to postural redistribution of blood volume. Although all ␣ 1B AR subtypes are variably expressed in the heart, studies investigating their role in myocardial contractility and structure have yielded variable results that are species, age, and model dependent. The influence of ␣ 1B AR on myocardial contractility has been assessed in overexpression and KO mutant models. ␣ 1B AR overexpression impairs myocardial contractility via signaling pathways that include G i coupling and cAMP and results in hypotension, autonomic failure, and cardiac hypertrophy. 22 This apparent contrast with our results, which demonstrate impaired contractility in a KO model, could be attributable to indiscriminate activation of multiple signaling pathways by ␣ 1B AR in the model overexpressing the receptor. Our results are more consistent with those of McClosky et al, 23 who, in a murine papillary muscle preparation, demonstrated a contribution of ␣ 1B AR and ␣ 1A AR to a triphasic response provoked by ␣ 1 AR stimulation, including an initial increase in contractility with subsequent depression and recovery. Overall, the role of ␣ 1B AR in modulating myocardial contractility in physiological conditions is likely to be modest and secondary to that of ␤-ARs. In contrast, in heart failure, ␣ 1 ARs are upregulated, whereas ␤-ARs are desensitized and downregulated. The potential importance of ␣ 1 AR was highlighted recently by the increased incidence of heart failure reported in patients administered nonselective ␣ 1 AR antagonists to treat hypertension and benign prostatic hypertrophy. 24 The role of ␣ 1 AR-specific subtypes in modulating contractility, specifically in pathophysiological conditions, remains to be investigated. Data from cell culture and transgenic models indicate that ␣ 1 ARs play an important role in modulating cardiac structure and involve the ␣ 1a AR and ␣ 1B AR subtypes with overexpression and deletion resulting in hypertrophy and atrophy, respectively, 22,25-27 although 2 studies in a mouse model indicate that ␣ 1A AR may not exert trophic changes in this species. 28, 29 However, our data indicating a dilated ventricle in ␣ 1B AR KO mice support the premise that this specific adrenergic subtype may exert a trophic effect in mice.
Open-Loop Baroreceptor Function and Cardiovascular Response to Selective Carotid Baroreceptor Unloading
In addition to our findings related to the important role of the ␣ 1B AR in cardiovascular regulation, we have applied the open-loop baroreceptor function technique to the mouse to interrogate baroreceptor-mediated control of the circulation. This technique has been useful for endogenous sympathoactivation in an attempt to address the hypothesis related to selective ␣ 1B AR junctional signaling in vivo. This technique provides a unique way of stimulating the sympathetic nervous system by selective carotid baroreceptor unloading. It is invaluable in assessing the efferent sympathetic response in this and other models of cardiovascular disease and promises to be as important in dissecting the contribution of signal transduction pathways in blood pressure regulation.
Limitations
It can be argued that the impaired responses to endogenous sympathoexcitation observed may be a function of impaired NE release in ␣ 1B AR KO mice. Although we did not measure sympathetic nerve activity or NE spillover in this study, there is no evidence that there is a difference in monoamine content in brain tissue from WT versus KO mice. 30 This suggests this is an unlikely mechanism to explain the results observed in vivo and in vitro. With regard to ␣ 2 ARs, it is possible that dysregulation of these receptors in the ␣ 1B AR KO mouse could explain the impaired responses to sympathoexcitation. Although there are postsynaptic ␣ 2 ARs that mediate coldinduced vasoconstriction, 31 visceral vascular ␣ 2 AR are primarily presynaptic and negatively regulate the release of NE and transmitters from the sympathetic nerve terminal. 32 Therefore, one would predict that pharmacological inhibition of ␣ 2 ARs alone would enhance the vasoconstriction induced by EFS in WT vessels and would have little effect on vessels treated with prazosin or vessels from ␣ 1B AR KO mice. We plan to address this issue in future experiments.
In summary, our data support the critical role of the ␣ 1B AR as the receptor subtype mediating sympathetic neurotransmission at the neuroeffector junction. These data support the concept that junctional ␣ 1 ARs are different from those that respond to circulating/exogenous NE. Together, our findings define a critical role for this receptor subtype in carotid arterial baroreceptor-stimulated sympathetic vasomotor tone, as well as maintenance of cardiac function and contractile reserve. This in turn has important implications for our understanding of the mechanisms associated with OI of dysautonomias, microgravity, and aging.
